1. Home
  2. ABOS vs GROV Comparison

ABOS vs GROV Comparison

Compare ABOS & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • GROV
  • Stock Information
  • Founded
  • ABOS 1996
  • GROV 2016
  • Country
  • ABOS United States
  • GROV United States
  • Employees
  • ABOS N/A
  • GROV N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • ABOS Health Care
  • GROV Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • GROV Nasdaq
  • Market Cap
  • ABOS 66.6M
  • GROV 53.5M
  • IPO Year
  • ABOS 2021
  • GROV N/A
  • Fundamental
  • Price
  • ABOS $1.07
  • GROV $1.35
  • Analyst Decision
  • ABOS Strong Buy
  • GROV Hold
  • Analyst Count
  • ABOS 3
  • GROV 1
  • Target Price
  • ABOS $7.33
  • GROV $1.20
  • AVG Volume (30 Days)
  • ABOS 215.0K
  • GROV 120.2K
  • Earning Date
  • ABOS 05-13-2025
  • GROV 05-14-2025
  • Dividend Yield
  • ABOS N/A
  • GROV N/A
  • EPS Growth
  • ABOS N/A
  • GROV N/A
  • EPS
  • ABOS N/A
  • GROV N/A
  • Revenue
  • ABOS N/A
  • GROV $193,427,000.00
  • Revenue This Year
  • ABOS N/A
  • GROV N/A
  • Revenue Next Year
  • ABOS N/A
  • GROV $6.22
  • P/E Ratio
  • ABOS N/A
  • GROV N/A
  • Revenue Growth
  • ABOS N/A
  • GROV N/A
  • 52 Week Low
  • ABOS $0.86
  • GROV $1.02
  • 52 Week High
  • ABOS $3.60
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 53.58
  • GROV 58.78
  • Support Level
  • ABOS $0.99
  • GROV $1.30
  • Resistance Level
  • ABOS $1.06
  • GROV $1.41
  • Average True Range (ATR)
  • ABOS 0.06
  • GROV 0.10
  • MACD
  • ABOS 0.01
  • GROV 0.02
  • Stochastic Oscillator
  • ABOS 80.00
  • GROV 77.78

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: